Stem cells in genetically-engineered mouse models of prostate cancer

Area of Science:

• Oncology
• Cancer Biology
• Stem Cell Research

Background:

• The cancer stem cell (CSC) model posits a hierarchical tumor structure where CSCs propagate tumors.
• Prostate cancer research increasingly supports the in vivo existence of CSCs.
• CSCs are implicated across various stages of prostate cancer progression, including metastatic and castration-resistant disease.

Purpose of the Study:

• To review evidence for cancer stem cells in prostate cancer.
• To highlight limitations in current methods for studying prostate CSCs.
• To emphasize the importance of the tumor microenvironment and niche in future CSC research.

Main Methods:

• Analysis of genetically engineered mouse (GEM) models for prostate cancer.
• In vivo studies of tumor progression and stem cell characteristics.
• Review of existing literature on prostate cancer stem cell research.

Main Results:

• GEM models provide evidence for CSCs in prostate cancer.
• CSCs are present from prostatic intraepithelial neoplasia (PIN) to advanced disease stages.
• Current functional evaluation of prostate CSCs in vitro and via transplantation is limited.

Conclusions:

• Cancer stem cells are likely key drivers in prostate cancer progression.
• Further investigation using GEM models within the native microenvironment is crucial.
• Understanding the CSC niche is vital for future therapeutic strategies.